- Home
- ADXN vs EVGN Comparison
ADXN vs EVGN Comparison
Compare ADXN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- EVGN
- Stock Information
- Founded
- ADXN 2002
- EVGN 1999
- Country
- ADXN Switzerland
- EVGN Israel
- Employees
- ADXN N/A
- EVGN N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- ADXN Health Care
- EVGN Industrials
- Exchange
- ADXN Nasdaq
- EVGN Nasdaq
- Market Cap
- ADXN 8.1M
- EVGN 9.7M
- IPO Year
- ADXN N/A
- EVGN N/A
- Fundamental
- Price
- ADXN $8.12
- EVGN $1.23
- Analyst Decision
- ADXN Strong Buy
- EVGN Strong Buy
- Analyst Count
- ADXN 1
- EVGN 1
- Target Price
- ADXN $30.00
- EVGN $12.00
- AVG Volume (30 Days)
- ADXN 3.0K
- EVGN 1.1M
- Earning Date
- ADXN 06-05-2025
- EVGN 05-21-2025
- Dividend Yield
- ADXN N/A
- EVGN N/A
- EPS Growth
- ADXN N/A
- EVGN N/A
- EPS
- ADXN 0.06
- EVGN N/A
- Revenue
- ADXN $701,260.00
- EVGN $8,511,000.00
- Revenue This Year
- ADXN N/A
- EVGN $68.62
- Revenue Next Year
- ADXN N/A
- EVGN $66.92
- P/E Ratio
- ADXN $1.06
- EVGN N/A
- Revenue Growth
- ADXN N/A
- EVGN 50.90
- 52 Week Low
- ADXN $6.51
- EVGN $0.95
- 52 Week High
- ADXN $13.27
- EVGN $9.00
- Technical
- Relative Strength Index (RSI)
- ADXN 54.21
- EVGN 57.21
- Support Level
- ADXN $7.70
- EVGN $1.09
- Resistance Level
- ADXN $8.38
- EVGN $1.23
- Average True Range (ATR)
- ADXN 0.32
- EVGN 0.07
- MACD
- ADXN 0.01
- EVGN 0.02
- Stochastic Oscillator
- ADXN 59.13
- EVGN 92.99
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.